Pramlintide (Symlin) studies: 145 papers with results
Page 2 of 3
- Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use.
Rubin RR · The Diabetes educator · 2009
Randomized controlled trial · 9 results
- Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
Herrmann K · Advances in therapy · 2016
Randomized controlled trial · 9 results
- Pramlintide for post-bariatric hypoglycaemia.
Sheehan A · Diabetes, obesity & metabolism · 2022
Non-randomized trial · 6 results
- Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
King AB · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2009
Non-randomized trial · 8 results
- Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.
Ratner R · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2005
Non-randomized trial · 3 results
- Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes.
Marrero DG · Diabetes care · 2007
Non-randomized trial · 5 results
- Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.
Karl D · Diabetes technology & therapeutics · 2007
Non-randomized trial · 7 results
- Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetes.
Fang J · The AAPS journal · 2013
Non-randomized trial · 4 results
- Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes.
Kellmeyer TA · Journal of clinical pharmacology · 2007
Non-randomized trial · 5 results
- The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus.
Borm AK · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1999
Non-randomized trial · 5 results
- Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
Levetan C · Diabetes care · 2003
Non-randomized trial · 12 results
- The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
Nyholm B · Metabolism: clinical and experimental · 1999
Non-randomized trial · 11 results
- Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans.
Woerle HJ · American journal of physiology. Endocrinology and metabolism · 2008
Non-randomized trial · 11 results
- Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects.
Orskov L · Diabetic medicine : a journal of the British Diabetic Association · 1999
Non-randomized trial · 5 results
- Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.
Huffman DM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2009
Non-randomized trial · 9 results
- Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Sherr JL · Diabetes care · 2016
Non-randomized trial · 8 results
- Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.
Kolterman OG · Diabetes care · 1995
Non-randomized trial · 5 results
- Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Weinzimer SA · Diabetes care · 2012
Non-randomized trial · 3 results
- Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.
Galderisi A · The Journal of clinical endocrinology and metabolism · 2018
Non-randomized trial · 5 results
- Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.
Tsoukas MA · Diabetes, obesity & metabolism · 2021
Non-randomized trial · 6 results
- Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial.
Thompson RG · Diabetes · 1997
Non-randomized trial · 11 results
- Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes.
Colburn WA · Journal of clinical pharmacology · 1996
Non-randomized trial · 7 results
- Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.
Hinshaw L · American journal of physiology. Endocrinology and metabolism · 2014
Non-randomized trial · 6 results
- An amylin analog used as a challenge test for Alzheimer's disease.
Zhu H · Alzheimer's & dementia (New York, N. Y.) · 2017
Non-randomized trial · 5 results
- Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.
Rubin RR · Current medical research and opinion · 2007
Non-randomized trial · 7 results
- Effects of pramlintide in patients with type 2 diabetes mellitus: an analysis using daily insulin dose tertiles.
Herrmann K · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2014
Non-randomized trial · 7 results
- Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.
Tao Q · Journal of Alzheimer's disease : JAD · 2018
Non-randomized trial · 8 results
- Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
Kovatchev BP · Diabetes technology & therapeutics · 2008
Observational study · 5 results
- A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
McCall AL · Diabetes technology & therapeutics · 2006
Observational study · 4 results
- Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
Sheffield CA · Pharmacotherapy · 2007
Case report or series · 1 result
- REDUCTION IN SUBCUTANEOUS INSULIN REQUIREMENTS IN TETRAPLEGIC TYPE 1 DIABETIC WITH CERVICAL SPINAL CORD INJURY FOLLOWING PRAMLINTIDE TREATMENT.
Salamone F · AACE clinical case reports · 2020
Case report or series · 1 result
- IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A · Nature · 2015
Animal study (in vivo) · mouse · 1 result
- Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
Adler BL · Neurobiology of aging · 2014
Animal study (in vivo) · mouse · 7 results
- Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
Zhu H · Molecular psychiatry · 2015
Animal study (in vivo) · mouse · 5 results
- Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
Patrick S · Journal of Alzheimer's disease : JAD · 2019
Animal study (in vivo) · mouse · 6 results
- Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer's disease.
Nassar SZ · Archives of physiology and biochemistry · 2020
Animal study (in vivo) · rat · 5 results
- [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
Leinung MC · Regulatory peptides · 2012
Animal study (in vivo) · mouse · 20 results
- Nephrectomy decreases amylin and pramlintide clearance in rats.
Vine W · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1998
Animal study (in vivo) · rat · 1 result
- From the pancreas to the amygdala: New brain area critical for ingestive and motivated behavior control exerted by amylin.
Byun S · iScience · 2025
Animal study (in vivo) · rat · 2 results
- Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming.
Yang Y · Cancers · 2022
Animal study (in vivo) · mouse · 8 results
- Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide.
Tyagi P · Pharmaceutics · 2022
Animal study (in vivo) · rat · 3 results
- Human IAPP is a contributor to painful diabetic peripheral neuropathy.
Albariqi MM · The Journal of clinical investigation · 2023
Animal study (in vivo) · mouse · 2 results
- Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.
Corrigan RR · Journal of Alzheimer's disease : JAD · 2023
Animal study (in vivo) · mouse · 5 results
- Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists.
Patch RJ · European journal of medicinal chemistry · 2022
Animal study (in vivo) · mouse · 1 result
- Effects of pramlintide on energy intake and food preference in rats given a choice diet.
Kern KA · Physiology & behavior · 2021
Animal study (in vivo) · rat · 10 results
- Chronic pramlintide decreases feeding via a reduction in meal size in male rats.
Kern KA · Peptides · 2024
Animal study (in vivo) · rat · 5 results
- Expression, purification, and biological activity of the recombinant pramlintide precursor.
Hu H · Applied microbiology and biotechnology · 2014
Animal study (in vivo) · 2 results
- Intranasal administration of dextran-pramlintide polyelectrolyte complex-coated nanoemulsions improves cognitive impairments in a mouse model of Alzheimer's disease.
Zuglianello C · International journal of biological macromolecules · 2024
Animal study (in vivo) · mouse · 9 results
- Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats.
Kern KA · Physiology & behavior · 2025
Animal study (in vivo) · rat · 8 results
- Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice.
Almeida MS · Endocrine · 2025
Animal study (in vivo) · mouse · 14 results